-
Professor Carl Hart says wide-scale legalization is a thorny issue but sees much more room for medical marijuana’s application. Read More
April 3, 2009 | In Politics & Policy, Health & Medicine
-
Carl Hart Takes On Drug Policy and Public Opinion
Carl Hart on America's public policy paradoxes. Read More
April 3, 2009 | In Politics & Policy
-
Carl Hart Discusses the Most Popular Drugs in America
The professor says alcohol is the most prevalent drug in America followed by tobacco and marijuana. Read More
April 3, 2009 | In Health & Medicine, Science & Tech
-
Carl Hart Discusses the Complexity of Drug Abuse
The professor talks about the conditions needed for a society to turn to hardcore use and if the recession might inspire an upswing. Read More
April 3, 2009 | In Health & Medicine, Science & Tech
-
Carl Hart Examines at Drugs in Pop Culture
The professor cites the myths and inaccuracies about drugs on TV and in film. Read More
April 3, 2009 | In Media & Internet
-
Carl Hart Explains His Drug Research Lab
The professor briefs us on his research at Columbia and describes why his project is important. Read More
April 3, 2009 | In Science & Tech
-
Carl Hart Describes Drug Addicts and Addiction
Invoking chocolate, the professor talks about the right way and the wrong way to define a drug addiction. Read More
April 3, 2009 | In Health & Medicine, Science & Tech
Dr. Hart is an Associate Professor of Psychology in both the Departments of Psychiatry and Psychology at Columbia University, and Director of the Residential Studies and Methamphetamine Research Laboratories at the New York State Psychiatric Institute. A major focus of Dr. Hart’s research is to understand complex interactions between drugs of abuse and the neurobiology and environmental factors that mediate human behavior and physiology.
He is the author or co-author of dozens of peer-reviewed scientific articles in the area of neuropsychopharmacology, co-author of the textbook, Drugs, Society, and Human Behavior, and a member of a NIH review group. Dr. Hart was recently elected to Fellow status by the American Psychological Association (Division 28) for his outstanding contribution to the field of psychology, specifically psychopharmacology and substance abuse.
